Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS

被引:1
|
作者
Jin, Xiu [1 ]
Liu, Feifei [1 ]
Zhang, Ya [2 ]
Ma, Yingying [3 ]
Yang, Linqing [3 ]
Wang, Yunfei [3 ]
Liu, Ying [3 ]
机构
[1] Jining Med Univ, Affiliated Hosp, Dept Pathol, Jining, Shandong, Peoples R China
[2] Jining Med Univ, Affiliated Hosp, Dept Obstet, Jining, Shandong, Peoples R China
[3] Jining Med Univ, Dept Gynecol, Affiliated Hosp, Jining, Shandong, Peoples R China
关键词
Cervical cancer; ASCUS; HPV E6/E7 mRNA; Menopause; Colposcope; CERVICAL-CANCER; PREVENTION; WOMEN; PERFORMANCE; POPULATION; LESIONS;
D O I
10.1186/s12905-023-02599-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To investigate the infection status of high-risk human papillomavirus (HR-HPV) E6/E7 mRNA in patients with a cytological diagnosis of "atypical squamous cells of undetermined significance" (ASCUS) and to analyze the pathogenic rate of different high-risk HPV subtypes combined with biopsy pathological results to provide a more accurate basis for managing ASCUS patients.Methods A total of 1387 patients with ASCUS and HPV E6/E7 mRNA positivity who were referred for colposcopy were retrospectively analyzed. They were divided into HPV16+, 18/45 + and other HR-HPV + groups premenopausal and postmenopausal groups. The pathological results of the biopsy were divided into the LSIL- group (including normal and low-grade squamous intraepithelial lesions) and the HSIL + group (including high-grade squamous intraepithelial lesions and higher lesions). SPSS was used for the analysis.Results The age group 31-40 years had the highest level of HPV16+, and HPV18/45 + was the highest in the 41-50 years group. The detection rates of HSIL + in the HPV16+, HPV18/45+, HPV 16/18/45 + and Other HR-HPV + groups were 48.4%, 18.8%, 43.9% and 15.0%, respectively. The infection rates of HPV16/18/45 in postmenopausal and premenopausal women were 42.4% and 34.3%, respectively. In the HPV18/45 group, the incidence of HSIL + was 30.0% in postmenopausal women and 15.0% in premenopausal women (P < 0.01). In the HPV 16 + and Other HR-HPV + groups, the incidence of HSIL + in postmenopausal patients was not significantly different from that in premenopausal patients. The incidence of cervical cancer in postmenopausal patients is significantly higher than that in premenopausal patients.Conclusions Colposcopy referral or further biopsy is recommended for all ASCUS patients with HPV16/18/45E6/E7 mRNA positivity and postmenopausal patients with HR-HPVE6/E7 mRNA positivity. For premenopausal ASCUS patients with other HR-HPV E6/E7 mRNA positivity, colposcopy should be performed if possible, depending on the specific situation, to achieve early detection and diagnosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Detection of Transcriptionally Active High-risk HPV in Patients With Head and Neck Squamous Cell Carcinoma as Visualized by a Novel E6/E7 mRNA In Situ Hybridization Method
    Bishop, Justin A.
    Ma, Xiao-Jun
    Wang, Hongwei
    Luo, Yuling
    Illei, Peter B.
    Begum, Shanaz
    Taube, Janis M.
    Koch, Wayne M.
    Westra, William H.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (12) : 1874 - 1882
  • [42] The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix
    Song, Seung-Hun
    Lee, Jae-Kwan
    Seok, Oye-Sun
    Saw, Ho-Suk
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : 732 - 738
  • [43] HPV E6/E7 mRNA与HPV E6/E7 DNA在筛查宫颈鳞状上皮内病变中的应用价值
    田莉
    陈文
    骆元斌
    黄小玲
    中国病理生理杂志, 2020, 36 (12) : 2300 - 2304
  • [44] HR-HPV E6/E7 mRNA在宫颈细胞学ASCUS分流诊断中的意义
    潘琼慧
    黄凌霄
    朱雪燕
    林涛
    朱雪琼
    浙江医学, 2016, 38 (13) : 1089 - 1092
  • [45] HPV E6/E7 mRNA、p16/Ki67检测在ASCUS中的诊断价值
    陈飞
    任琛琛
    杨立
    张小安
    王朝昕
    魏心怡
    潘雪景
    现代妇产科进展, 2019, 28 (01) : 54 - 57
  • [46] HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis
    Luo, Rong-Zhen
    Chen, Shu-Lin
    Li, Mei
    Li, Yue
    Yang, Xia
    Liu, Li-Li
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [47] The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China
    Zhang, Shao-Kai
    Guo, Zhen
    Wang, Peng
    Kang, Le-Ni
    Jia, Man-Man
    Wu, Ze-Ni
    Chen, Qiong
    Cao, Xiao-Qin
    Zhao, Dong-Mei
    Guo, Pei-Pei
    Sun, Xi-Bin
    Zhang, Jian-Gong
    Qiao, You-Lin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [48] Laryngeal Cancer, HPV DNA vs E6/E7 mRNA Test: A Systematic Review
    Fusconi, Massimo
    Campo, Flaminia
    Gallo, Andrea
    Zambetti, Giampietro
    Martellucci, Salvatore
    Seccia, Annalisa
    de Vincentiis, Marco
    JOURNAL OF VOICE, 2017, 31 (02) : 248.e1 - 248.e5
  • [49] The Expression of HPV E6/E7 mRNA In Situ Hybridization in HPV Typing-negative Cervical Cancer
    Xu, Yating
    Sun, Yonghong
    Chang, Hui
    Cai, Jingjing
    Cao, Chengcheng
    Zhang, Baogang
    Zhang, Youzhong
    Liu, Yuzhen
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (01) : 11 - 20
  • [50] HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis
    Rong-Zhen Luo
    Shu-Lin Chen
    Mei Li
    Yue Li
    Xia Yang
    Li-Li Liu
    Cancer Cell International, 21